Global Primary Ovarian Insufficiency (POI) Market Research Report 2023

Report ID: 1733994 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hormone Replacement Therapy (HRT)
        1.2.3 Calcium and Vitamin D Supplements
        1.2.4 In Vitro Fertilization (IVF)
        1.2.5 Stem Cell Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Primary Ovarian Insufficiency (POI) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Less than 20 Years Old
        1.3.3 20 to 30 Years Old
        1.3.4 30 to 45 Years Old
        1.3.5 45 Years Old and Older
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Primary Ovarian Insufficiency (POI) Market Perspective (2017-2028)
    2.2 Primary Ovarian Insufficiency (POI) Growth Trends by Region
        2.2.1 Primary Ovarian Insufficiency (POI) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Primary Ovarian Insufficiency (POI) Historic Market Size by Region (2017-2022)
        2.2.3 Primary Ovarian Insufficiency (POI) Forecasted Market Size by Region (2023-2028)
    2.3 Primary Ovarian Insufficiency (POI) Market Dynamics
        2.3.1 Primary Ovarian Insufficiency (POI) Industry Trends
        2.3.2 Primary Ovarian Insufficiency (POI) Market Drivers
        2.3.3 Primary Ovarian Insufficiency (POI) Market Challenges
        2.3.4 Primary Ovarian Insufficiency (POI) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Primary Ovarian Insufficiency (POI) Players by Revenue
        3.1.1 Global Top Primary Ovarian Insufficiency (POI) Players by Revenue (2017-2022)
        3.1.2 Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Players (2017-2022)
    3.2 Global Primary Ovarian Insufficiency (POI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Primary Ovarian Insufficiency (POI) Revenue
    3.4 Global Primary Ovarian Insufficiency (POI) Market Concentration Ratio
        3.4.1 Global Primary Ovarian Insufficiency (POI) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Primary Ovarian Insufficiency (POI) Revenue in 2021
    3.5 Primary Ovarian Insufficiency (POI) Key Players Head office and Area Served
    3.6 Key Players Primary Ovarian Insufficiency (POI) Product Solution and Service
    3.7 Date of Enter into Primary Ovarian Insufficiency (POI) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Primary Ovarian Insufficiency (POI) Breakdown Data by Type
    4.1 Global Primary Ovarian Insufficiency (POI) Historic Market Size by Type (2017-2022)
    4.2 Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Type (2023-2028)
5 Primary Ovarian Insufficiency (POI) Breakdown Data by Application
    5.1 Global Primary Ovarian Insufficiency (POI) Historic Market Size by Application (2017-2022)
    5.2 Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Primary Ovarian Insufficiency (POI) Market Size (2017-2028)
    6.2 North America Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022)
    6.3 North America Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Primary Ovarian Insufficiency (POI) Market Size (2017-2028)
    7.2 Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022)
    7.3 Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size (2017-2028)
    8.2 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Primary Ovarian Insufficiency (POI) Market Size (2017-2028)
    9.2 Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022)
    9.3 Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size (2017-2028)
    10.2 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Primary Ovarian Insufficiency (POI) Introduction
        11.1.4 Pfizer Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Primary Ovarian Insufficiency (POI) Introduction
        11.2.4 Bayer Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Primary Ovarian Insufficiency (POI) Introduction
        11.3.4 Novartis Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Bioscience Institute
        11.4.1 Bioscience Institute Company Detail
        11.4.2 Bioscience Institute Business Overview
        11.4.3 Bioscience Institute Primary Ovarian Insufficiency (POI) Introduction
        11.4.4 Bioscience Institute Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.4.5 Bioscience Institute Recent Development
    11.5 Johns Hopkins Medicine
        11.5.1 Johns Hopkins Medicine Company Detail
        11.5.2 Johns Hopkins Medicine Business Overview
        11.5.3 Johns Hopkins Medicine Primary Ovarian Insufficiency (POI) Introduction
        11.5.4 Johns Hopkins Medicine Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.5.5 Johns Hopkins Medicine Recent Development
    11.6 Mayo Clinic
        11.6.1 Mayo Clinic Company Detail
        11.6.2 Mayo Clinic Business Overview
        11.6.3 Mayo Clinic Primary Ovarian Insufficiency (POI) Introduction
        11.6.4 Mayo Clinic Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.6.5 Mayo Clinic Recent Development
    11.7 Baptist Health
        11.7.1 Baptist Health Company Detail
        11.7.2 Baptist Health Business Overview
        11.7.3 Baptist Health Primary Ovarian Insufficiency (POI) Introduction
        11.7.4 Baptist Health Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.7.5 Baptist Health Recent Development
    11.8 Indira IVF
        11.8.1 Indira IVF Company Detail
        11.8.2 Indira IVF Business Overview
        11.8.3 Indira IVF Primary Ovarian Insufficiency (POI) Introduction
        11.8.4 Indira IVF Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022)
        11.8.5 Indira IVF Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormone Replacement Therapy (HRT)
    Table 3. Key Players of Calcium and Vitamin D Supplements
    Table 4. Key Players of In Vitro Fertilization (IVF)
    Table 5. Key Players of Stem Cell Therapy
    Table 6. Key Players of Others
    Table 7. Global Primary Ovarian Insufficiency (POI) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Primary Ovarian Insufficiency (POI) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Primary Ovarian Insufficiency (POI) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Primary Ovarian Insufficiency (POI) Market Share by Region (2017-2022)
    Table 11. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Primary Ovarian Insufficiency (POI) Market Share by Region (2023-2028)
    Table 13. Primary Ovarian Insufficiency (POI) Market Trends
    Table 14. Primary Ovarian Insufficiency (POI) Market Drivers
    Table 15. Primary Ovarian Insufficiency (POI) Market Challenges
    Table 16. Primary Ovarian Insufficiency (POI) Market Restraints
    Table 17. Global Primary Ovarian Insufficiency (POI) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Primary Ovarian Insufficiency (POI) Market Share by Players (2017-2022)
    Table 19. Global Top Primary Ovarian Insufficiency (POI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Ovarian Insufficiency (POI) as of 2021)
    Table 20. Ranking of Global Top Primary Ovarian Insufficiency (POI) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Primary Ovarian Insufficiency (POI) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Primary Ovarian Insufficiency (POI) Product Solution and Service
    Table 24. Date of Enter into Primary Ovarian Insufficiency (POI) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Primary Ovarian Insufficiency (POI) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Type (2017-2022)
    Table 28. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Type (2023-2028)
    Table 30. Global Primary Ovarian Insufficiency (POI) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Application (2017-2022)
    Table 32. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Application (2023-2028)
    Table 34. North America Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Pfizer Company Detail
    Table 45. Pfizer Business Overview
    Table 46. Pfizer Primary Ovarian Insufficiency (POI) Product
    Table 47. Pfizer Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 48. Pfizer Recent Development
    Table 49. Bayer Company Detail
    Table 50. Bayer Business Overview
    Table 51. Bayer Primary Ovarian Insufficiency (POI) Product
    Table 52. Bayer Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 53. Bayer Recent Development
    Table 54. Novartis Company Detail
    Table 55. Novartis Business Overview
    Table 56. Novartis Primary Ovarian Insufficiency (POI) Product
    Table 57. Novartis Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 58. Novartis Recent Development
    Table 59. Bioscience Institute Company Detail
    Table 60. Bioscience Institute Business Overview
    Table 61. Bioscience Institute Primary Ovarian Insufficiency (POI) Product
    Table 62. Bioscience Institute Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 63. Bioscience Institute Recent Development
    Table 64. Johns Hopkins Medicine Company Detail
    Table 65. Johns Hopkins Medicine Business Overview
    Table 66. Johns Hopkins Medicine Primary Ovarian Insufficiency (POI) Product
    Table 67. Johns Hopkins Medicine Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 68. Johns Hopkins Medicine Recent Development
    Table 69. Mayo Clinic Company Detail
    Table 70. Mayo Clinic Business Overview
    Table 71. Mayo Clinic Primary Ovarian Insufficiency (POI) Product
    Table 72. Mayo Clinic Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 73. Mayo Clinic Recent Development
    Table 74. Baptist Health Company Detail
    Table 75. Baptist Health Business Overview
    Table 76. Baptist Health Primary Ovarian Insufficiency (POI) Product
    Table 77. Baptist Health Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 78. Baptist Health Recent Development
    Table 79. Indira IVF Company Detail
    Table 80. Indira IVF Business Overview
    Table 81. Indira IVF Primary Ovarian Insufficiency (POI) Product
    Table 82. Indira IVF Revenue in Primary Ovarian Insufficiency (POI) Business (2017-2022) & (US$ Million)
    Table 83. Indira IVF Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Primary Ovarian Insufficiency (POI) Market Share by Type: 2021 VS 2028
    Figure 2. Hormone Replacement Therapy (HRT) Features
    Figure 3. Calcium and Vitamin D Supplements Features
    Figure 4. In Vitro Fertilization (IVF) Features
    Figure 5. Stem Cell Therapy Features
    Figure 6. Others Features
    Figure 7. Global Primary Ovarian Insufficiency (POI) Market Share by Application in 2021 & 2028
    Figure 8. Less than 20 Years Old Case Studies
    Figure 9. 20 to 30 Years Old Case Studies
    Figure 10. 30 to 45 Years Old Case Studies
    Figure 11. 45 Years Old and Older Case Studies
    Figure 12. Primary Ovarian Insufficiency (POI) Report Years Considered
    Figure 13. Global Primary Ovarian Insufficiency (POI) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Primary Ovarian Insufficiency (POI) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Primary Ovarian Insufficiency (POI) Market Share by Region: 2021 VS 2028
    Figure 16. Global Primary Ovarian Insufficiency (POI) Market Share by Players in 2021
    Figure 17. Global Top Primary Ovarian Insufficiency (POI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Ovarian Insufficiency (POI) as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Primary Ovarian Insufficiency (POI) Revenue in 2021
    Figure 19. North America Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Primary Ovarian Insufficiency (POI) Market Share by Country (2017-2028)
    Figure 21. United States Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Primary Ovarian Insufficiency (POI) Market Share by Country (2017-2028)
    Figure 25. Germany Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Share by Region (2017-2028)
    Figure 33. China Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Primary Ovarian Insufficiency (POI) Market Share by Country (2017-2028)
    Figure 41. Mexico Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Share by Country (2017-2028)
    Figure 45. Turkey Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Pfizer Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 48. Bayer Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 50. Bioscience Institute Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 51. Johns Hopkins Medicine Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 52. Mayo Clinic Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 53. Baptist Health Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 54. Indira IVF Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Bayer
Novartis
Bioscience Institute
Johns Hopkins Medicine
Mayo Clinic
Baptist Health
Indira IVF
Frequently Asked Questions
Primary Ovarian Insufficiency (POI) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Primary Ovarian Insufficiency (POI) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Primary Ovarian Insufficiency (POI) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports